8-KLeadership Changes

UNITEDHEALTH GROUP INC 8-K Report, Executive Changes (Nov 2, 2012)

Filed November 2, 2012For Securities:UNH

Summary

This Form 8-K filing by UnitedHealth Group Inc. (UNH) on November 1, 2012, details significant events primarily related to the company's acquisition of approximately 60% of Amil Participações S.A. ("Amil"), a major Brazilian healthcare provider, which closed on October 26, 2012. The filing also announces the election of Dr. Edson Bueno, CEO of Amil, to UnitedHealth Group's Board of Directors. While Dr. Bueno will not receive additional compensation for his board service, he is compensated by a subsidiary of UnitedHealth Group for his CEO role at Amil. The acquisition involved a significant cash transaction and a commitment from Dr. Bueno and his partner to retain a 10% stake in Amil for at least five years, with put and call options subsequently defined. Furthermore, the report discloses ongoing business relationships between Amil and entities in which Dr. Bueno has a significant ownership interest, such as DASA (diagnostic services) and several hospitals. These relationships, which existed prior to the acquisition, have been ratified by the Audit Committee. The company believes the terms of these contracts, including discounts and lease payments, are comparable to market rates. The filing also outlines a transaction where Amil sold 80% of its air taxi business, Aeromil, to Dr. Bueno to comply with foreign ownership regulations, with Amil retaining significant profit rights and an option to repurchase the stake.

Key Highlights

  • 1UnitedHealth Group acquired approximately 60% of Amil Participações S.A. ("Amil"), Brazil's largest healthcare organization, on October 26, 2012.
  • 2Dr. Edson Bueno, CEO of Amil, was elected to UnitedHealth Group's Board of Directors, effective October 29, 2012.
  • 3Dr. Bueno will not receive additional compensation for his Board service.
  • 4The acquisition involved the purchase of shares in Amil's controlling shareholder from Dr. Bueno and other selling shareholders.
  • 5Dr. Bueno and a partner committed to retaining approximately 10% of Amil shares for at least five years, with specific put and call option arrangements.
  • 6The report details existing business relationships between Amil and entities owned by Dr. Bueno, including diagnostic services provider DASA and several hospitals, which have been ratified by the Audit Committee.
  • 7Amil sold 80% of its air taxi business, Aeromil, to Dr. Bueno to comply with Brazilian foreign ownership rules, with Amil retaining profit rights and a repurchase option.

Frequently Asked Questions

The acquisition of approximately 60% of Amil represents a significant expansion for UnitedHealth Group into the Brazilian healthcare market, which is described as the largest in Brazil. This move diversifies the company's geographic footprint and operational base.

Dr. Edson Bueno, as the CEO of Amil, was appointed to the Board following UnitedHealth Group's acquisition of a controlling stake in Amil. This appointment likely ensures continuity and provides valuable insights into the Brazilian healthcare operations from a key leader of the acquired company.

The filing states that the Audit Committee of the Board of Directors has ratified these relationships. UnitedHealth Group believes that the contract terms, including discounts and lease payments, are equal to or better than what could be obtained from unaffiliated third parties and are comparable to market rates.

While specific financial figures for the acquisition price are not detailed in this 8-K beyond the per-share price of Amil's controlling shareholder, the filing indicates substantial payments to DASA ($156 million YTD 2012) and to hospitals ($107 million YTD 2012 for services and leases). Amil also anticipates payments between $17-$20 million for Aeromil services in 2013. Dr. Bueno committed to invest approximately $470 million in UnitedHealth Group common shares.